LAUREN HORN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WAYNESBORO, VA NPI 1205409141
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VA ABBVIE INC. All categories
General Payments — all program years on this page
$285.02
- Category: General Payments
- Program years: PY2021–2022
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $132.58 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $132.58 | 7 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $36.46 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.37 | 2 |
| Acerta Pharma LLC | $23.88 | 1 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $23.48 | 1 |
| Amgen Inc. | $19.39 | 1 |
By program year
Records — PY2022 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 892169493 | ABBVIE INC. | $19.41 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 892169495 | ABBVIE INC. | $17.05 | 06/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 914650849 | AstraZeneca Pharmaceuticals LP | $23.88 | 05/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 923880291 | Biohaven Pharmaceutical Holding Company Ltd. | $23.48 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 939614087 | Amgen Inc. | $19.39 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 956070345 | Takeda Pharmaceuticals U.S.A., Inc. | $13.87 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 956070351 | Takeda Pharmaceuticals U.S.A., Inc. | $15.50 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.